Ublituximab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Ublituximab Usage And Synthesis

Uses

Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects[1].

References

[1] Matthew Lunning, et al. Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood. 2019 Nov 21;134(21):1811-1820. DOI:10.1182/blood.2019002118

Ublituximab(1174014-05-1)Related Product Information

• Cemiplimab
• Siltuximab
• Naratuximab
• Pembrolizumab
• Tucotuzumab Celmoleukin
• Sifalimumab
• Otelixizumab
• Tisotumab
• Rozanolixizumab
• Hu1D10